Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Amphastar Pharmaceuticals (AMPH) Return on Invested Capital: 2014-2025

Historic Return on Invested Capital for Amphastar Pharmaceuticals (AMPH) over the last 10 years, with Sep 2025 value amounting to 0.10%.

  • Amphastar Pharmaceuticals' Return on Invested Capital fell 6.00% to 0.10% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.10%, marking a year-over-year decrease of 6.00%. This contributed to the annual value of 0.15% for FY2024, which is 4.00% down from last year.
  • As of Q3 2025, Amphastar Pharmaceuticals' Return on Invested Capital stood at 0.10%, which was down 21.43% from 0.12% recorded in Q2 2025.
  • Amphastar Pharmaceuticals' Return on Invested Capital's 5-year high stood at 0.17% during Q2 2024, with a 5-year trough of 0.01% in Q1 2021.
  • For the 3-year period, Amphastar Pharmaceuticals' Return on Invested Capital averaged around 0.14%, with its median value being 0.13% (2023).
  • Its Return on Invested Capital has fluctuated over the past 5 years, first climbed by 11bps in 2022, then dropped by 6bps in 2025.
  • Over the past 5 years, Amphastar Pharmaceuticals' Return on Invested Capital (Quarterly) stood at 0.10% in 2021, then rose by 2bps to 0.13% in 2022, then rose by 3bps to 0.15% in 2023, then dropped by 1bps to 0.15% in 2024, then decreased by 6bps to 0.10% in 2025.
  • Its Return on Invested Capital stands at 0.10% for Q3 2025, versus 0.12% for Q2 2025 and 0.13% for Q1 2025.